Interestingly, altered GSDM expression is observed in IBD (Bulek et al., 2020; Tan et al., 2020; Rana et al., 2022), in which dysbiosis is thought to exert a pathogenic role (Ni et al., 2017). This evidence concerns the gene GSDMA and inflammatory bowel disease.